Literature DB >> 1330115

Ganciclovir therapy of congenital cytomegalovirus disease.

H Reigstad1, R Bjerknes, T Markestad, H Myrmel.   

Abstract

A newborn with cytomegalovirus disease with cerebral involvement was treated with ganciclovir for 21 days. The treatment resulted in only temporary cessation of virus shedding in the urine and probably had no ameliorating effect on the long-term clinical outcome.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1330115     DOI： 10.1111/j.1651-2227.1992.tb12341.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN： 0803-5253            Impact factor:   2.299


  5 in total

Review 1.  Selecting neonates with congenital cytomegalovirus infection for ganciclovir therapy.

Authors:  Koenraad Smets; Kris De Coen; Ingeborg Dhooge; Lieve Standaert; Sabrina Laroche; Ludo Mahieu; Noël Logghe; Veerle Cossey; An Boudewyns
Journal:  Eur J Pediatr       Date:  2006-06-20       Impact factor: 3.183

2.  Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.

Authors:  Jacob Amir; Dana G Wolf; Itzhak Levy
Journal:  Eur J Pediatr       Date:  2010-03-16       Impact factor: 3.183

Review 3.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 4.  Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.

Authors:  Maria Grazia Revello; Giuseppe Gerna
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 5.  Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.